norfloxacin has been researched along with cisapride in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Cumsille, F; Defilippi, C; Hurtado, C; Madrid, AM; Venegas, M | 1 |
| Gupta, R; Murthy, NS; Sandhu, BS; Sarin, SK; Sharma, J; Singh, J | 1 |
| Bhatt, G; Itha, S; Sharma, A | 1 |
2 trial(s) available for norfloxacin and cisapride
| Article | Year |
|---|---|
Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cisapride; Female; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Norfloxacin; Severity of Illness Index; Time Factors | 2001 |
Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
Topics: Adult; Analysis of Variance; Anti-Infective Agents; Ascites; Chi-Square Distribution; Cisapride; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Incidence; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Peritonitis; Prospective Studies; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome | 2005 |
4 other study(ies) available for norfloxacin and cisapride
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
Topics: Anti-Infective Agents; Ascites; Bacterial Infections; Cisapride; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Incidence; Liver Cirrhosis; Norfloxacin; Peritonitis; Treatment Outcome | 2006 |